Why the study?
Atrial fibrillation and heart failure often coexist and exacerbate each other, creating management challenges and debated treatment strategies.
Answers are grounded in this paper and cite their sources.
This review summarizes the pathophysiological links and management strategies for patients with coexisting atrial fibrillation and heart failure.
Atrial fibrillation (AF) and heart failure (HF) are both highly prevalent diseases and are accompanied by a significant disease burden and increased mortality. Although the conditions may exist independently, they often go hand in hand as each is able to provoke, sustain, and aggravate the other. In addition, the diseases share a risk profile with several coinciding cardiovascular risk factors, promoting the odds of developing both AF and HF separately from each other. When the diseases coexist, this provides additional challenges but also opportunities for the optimal treatment. The recommended management of the comorbidities has been much debated in the past decades. In this review, we describe the pathophysiological coherence of AF and HF, illustrate the current knowledge on the management of them as comorbidities of each other and look forward to future developments in this field.
No takes yet. Share an insight, caveat, or question.
Verhaert et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: